JLE - European Journal of Dermatology
US$ 20.19
bpc 157 sciatica clinical trial BPC-157: Disc Herniation & Lower Back Pain: Canadian Guide bpc 157 for sciatica Peptide
Description
BPC-157 is the notable exception: native oral activity without formulation intervention
To reduce the oxidative degradation, the authors proposed the use of methionine (10 mM) as an antioxidant (Doshi et al., 2020b)
Without controlled body composition measurements, it's hard to interpret anecdotal reports
First, using HPLC and HPLC-associated radioactive detector, we identified six radioactive components, in addition to prototype [ 3 H]BPC157, in rat plasma collected at 0.05, 0.167, 1, 8, and 24 h after administration (Supplementary Figure S1)
What about GHK-Cu (copper peptide)
